Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.
- DOI
- 10.1016/j.rmed.2026.109075
- Published
- 2026 Oct
- Container
- Respiratory medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rmed.2026.109075,
title = {Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.},
author = {Milger K and Dorscheid D and Gessner C and Hilberg O and Llanos JP and Nåtman J and Urbanski H and Clarke DL and Emmanuel B and Stjepanovic N},
year = {2026},
journal = {Respiratory medicine},
doi = {10.1016/j.rmed.2026.109075},
url = {https://doi.org/10.1016/j.rmed.2026.109075}
}RIS
TY - JOUR TI - Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study. AU - Milger K AU - Dorscheid D AU - Gessner C AU - Hilberg O AU - Llanos JP AU - Nåtman J AU - Urbanski H AU - Clarke DL AU - Emmanuel B AU - Stjepanovic N PY - 2026 JO - Respiratory medicine DO - 10.1016/j.rmed.2026.109075 UR - https://doi.org/10.1016/j.rmed.2026.109075 ER -
APA
K, M., D, D., C, G., O, H., JP, L., J, N., H, U., DL, C., B, E., & N, S. (2026). Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.. Respiratory medicine. https://doi.org/10.1016/j.rmed.2026.109075
Source records
- pubmed · retrieved 2026-09-26T14:57:47.344Z